Increased dose-intensity of gemcitabine in advanced non small cell lung cancer (NSCLC): a multicenter phase II study in elderly patients from the "polmone toscano group" (POLTO).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples